Diabetic patient starts producing insulin on his own after implantation of genetically modified cells
A man from type 1 diabetes mellitus became the world’s first patient to start producing his own insulin after transplantation of genetically modified cells.
CRISPR gene editing tool helps partially restore vision to blind patients in clinical trials
We are talking about patients with Leber’s amaurosis, a rare congenital retinal disease that affects about one in 40 thousand newborns. The genetic mutation leads to complete blindness in about a third of patients, and there are currently no approved treatment options.
Spelling error report
The following text will be sent to our editors: